Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations: American Journal of Cardiology

F. D'Ascenzo, U. Barbero, M. Abdirashid, D. Trabattoni, G. Boccuzzi, N. Ryan, G. Quadri, D. Capodanno, G. Venuti, S. Muscoli, F. Tomassini, M. Autelli, A. Montabone, W. Wojakowski, A. Rognoni, D. Gallo, R. Parma, L. De Luca, F. Figini, S. MitomoA. Montefusco, A. Mattesini, W. Wańha, M. Protasiewicz, G. Smolka, Z. Huczek, C. Rolfo, B. Cortese, A. Chieffo, W. Kuliczowki, I. Nuñez-Gil, U. Morbiducci, F. Ugo, G. Marengo, M. Iannaccone, E. Cerrato, C.D. Mario, C. Moretti, M. D'Amico, F. Varbella, T.F. Lüscher, I. Sheiban, J. Escaned, F. Romeo, M. Rinaldi, G.M. De Ferrari, G. Helft

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations: American Journal of Cardiology'. Together they form a unique fingerprint.

Medicine & Life Sciences